OVERVIEW

ASH Review 2020: Current Updates in Hematologic Diseases is organized by University of Kansas Medical Center (KUMC).

Event Date: Saturday, January 23, 2021

Event Time: 8:00 AM - 2:30 PM (Central)

Accreditation:
The University of Kansas Medical Center Office of Continuing Medical Education designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives:
• Analyze positive & negative trials in hematologic cancers including AML, MDS, MN, Lymphoma and Myelomaand how this changes current standards of care.
• Discuss the indications for transplant and cellular therapies in various hematologic neoplasms including myeloid diseases, lymphoma and myeloma.
• Examine the most useful data from the Annual ASH meeting about none malignant hematology.
• Assess the best utilization of novel agents, expected outcomes and data in support of their efficacy for lymphoma and myeloma.